Lonza Group - Cutanogen Corporation


Cutanogen Corporation is a subsidiary of Lonza which is developing Engineered Skin Substitute (ESS), an autologous skin replacement product for the treatment of Stage 3 and Stage 4 intractable severe burns. Engineered Skin substitute (ESS): Phase 1/ Early Phase 2 product candidate that has potential to be a revolutionary new treatment for severe burns.

Cutanogen Corporation is a subsidiary of Lonza which is developing Engineered Skin Substitute (ESS), an autologous skin replacement product for the treatment of Stage 3 and Stage 4 intractable severe burns. Engineered Skin substitute (ESS): Phase 1/ ...Show all

Company (Acquired)

Phone: +41 61 316 81 11

Fax:

Muenchensteinerstrasse 38

Basel, CH-4002
Switzerland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Lonza Group - Cutanogen Corporation $0M Nov 18, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Lonza Group - Cutanogen Corporation Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)